Alternative options for treatment-experienced people with HIV
- PMID: 37139652
- DOI: 10.1097/QAD.0000000000003550
Alternative options for treatment-experienced people with HIV
Comment on
-
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV.AIDS. 2023 Jun 1;37(7):1057-1064. doi: 10.1097/QAD.0000000000003513. Epub 2023 Mar 3. AIDS. 2023. PMID: 36927740 Clinical Trial.
References
-
- van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals . AIDS 2010; 24:1527–1535.
-
- Legarth RA, Ahlstrom MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study . J Acquir Immune Defic Syndr 2016; 71:213–218.
-
- Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies . Lancet HIV 2017; 4:e349–e356.
-
- Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, et al. Increases in duration of first highly active antiretroviral therapy over time (1996–2009) and associated factors in the Multicenter AIDS Cohort Study . J Acquir Immune Defic Syndr 2014; 65:57–64.
-
- Kagan RM, Dunn KJ, Snell GP, Nettles RE, Kaufman HW. Trends in HIV-1 drug resistance mutations from a U.S. Reference Laboratory from 2006 to 2017 . AIDS Res Hum Retroviruses 2019; 35:698–709.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical